Home > Drug Search >
  • company_query: ArmaGen
  •   > 
Drug Filter
Category:
chemistry (11) biology (15)
Status:
BLA Filing (1) Phase Ⅲ (2) Phase Ⅱ (15) Phase Ⅰ (7)
Clinical Stage:
Pending (4) Active (16) Discontinued (6)
Bio-Type:
Cell therapy (1) Vaccine (5) Recombinant cytokines (1) Recombinant hormone (1) Bispecific antibody (1) Whole antibody (1) ADC (1) Fusion protein (1)
Indication:
Squamous cell cancer (1) Acute myeloid Leukemia (AML) (1) Breast cancer (3) Avian influenza (1) Asphyxia (1) HCV infection (1) Heart failure (1) Hepatocellular carcinoma (HCC) (2) Hypertension (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (2) Ovarian cancer (3) Pancreatic cancer (1) Peripheral arterial disease (PAD) (1) Post-polycythemia vera (1) Middle East respiratory syndrome coronavirus (1) Zika virus infection (1) Small cell lung cancer (SCLC) (1) Solid tumours (3) Head and neck cancer (1) Colorectal cancer (3) Varicose ulcer (1) Cirrhosis (1) Chronic heart failure (1) Mucopolysaccharidosis II (Hunter syndrome) (1) Mucopolysaccharidosis I (1) Portal hypertension (1) Acute heart failure (1) venous stasis ulcers (1) Coronary heart disease (1) Gastroparesis (1) Aortic valve stenosis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top